Hjem › Leversygdomme › Arkansas
Leversygdomme kliniske forsøg i Arkansas
4 studier for Leversygdomme søger deltagere på steder i Arkansas.
Byer i Arkansas
Officiel studietekst (engelsk)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Arkansas Gastroenterology, P.A, Little Rock
- ARcare Center for Clinical Research, Little Rock
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 9. sep. 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Little Rock
- 89bio Clinical Study Site, North Little Rock
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Little Rock
- 89bio Clinical Study Site, North Little Rock
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 3. sep. 2026 · NCT06419374Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
- Central Arkansas Veterans Healthcare System , Little Rock, AR, Little Rock
Rekrutterer
Alder 18 til 80 · Alle køn · Opdateret 25. jun. 2026 · NCT06068491Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.